Evidence map›Paper›PMID 41155340›Full record

ArticleInternational journal of molecular sciences2025

Application of Modulators of Ca

Elena A Belyaeva, Tatyana V Sokolova

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Elena A BelyaevaSechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, 44 Thorez Avenue, Saint-Petersburg 194223, Russia.ORCID 0000-0003-3663-3881
Tatyana V SokolovaSechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, 44 Thorez Avenue, Saint-Petersburg 194223, Russia.

Funding

Federal Agency of Scientific Organizations of Russia No. 075-00263-25-00
6 · The paper itself

Abstract

As we found earlier, paxilline (a Penicillium paxilli mycotoxin and blocker of Ca

Indexed as

CadmiumLarge-Conductance Calcium-Activated Potassium ChannelsAnimalsApoptosisBenzimidazolesCell SurvivalIndolesMembrane Potential, MitochondrialPC12 CellsRatsReactive Oxygen SpeciesBenzimidazolesCadmiumIndolesLarge-Conductance Calcium-Activated Potassium ChannelsNS 1619paxillineReactive Oxygen SpeciesAS-30D ascites hepatomaCa2+-activated big-conductance potassium channelsCd2+-induced mitochondrial dysfunction-mediated cytotoxicitymitochondrial respiratory chainNS004NS1619paxillinePC12 pheochromocytomareactive oxygen species

Identifiers

PMID41155340
PMCPMC12564761

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.